The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tayton-martin Helen Katrina since 2020.
This trader's CIK number is 1661780.
At the time of last reporting, Tayton-martin Helen Katrina was the Chief Business Officer of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP).
Also see all insider trading activities at Adaptimmune Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ADAP | 0 | $0 | 0 | $0 | 1,785,000 | $280,245 |
| 2020 | ADAP | 0 | $0 | 300,000 | $2,198,200 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-03 | ADAP | Option Ex | 1,785,000 | .16 | 280,245 |
| 2020-08-03 | ADAP | Sale | 200,000 | 8.74 | 1,748,200 |
| 2020-01-13 | ADAP | Sale | 100,000 | 4.50 | 450,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tayton-martin Helen Katrina (Chief Business Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.